Reports for APO-SITAGLIPTIN/METFORMIN XR
Brand name
APO-SITAGLIPTIN/METFORMIN XR
Company Name
APOTEX INC
|
Drug Identification Number
02506289 |
Ingredients
SITAGLIPTIN METFORMIN HYDROCHLORIDE |
Ingredient Strength
50 MG 1000 MG |
ATC Code
A10BDA10BD |
ATC Descriptor
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| APO-SITAGLIPTIN/METFORMIN XR | 500 BTL | Resolved | 2022-12-16 | 2023-01-09 | 178772 |
| APO-SITAGLIPTIN/METFORMIN XR | 60 BTL | Resolved | 2022-12-16 | 2023-01-20 | 178775 |
| APO-SITAGLIPTIN/METFORMIN XR | 60 BTL | Resolved | 2023-03-02 | 2024-02-02 | 185973 |
| APO-SITAGLIPTIN/METFORMIN XR | 100 BTL | Resolved | 2023-03-02 | 2024-02-02 | 185976 |
| APO-SITAGLIPTIN/METFORMIN XR | 500 BTL | Resolved | 2023-03-02 | 2024-02-02 | 185982 |
| APO-SITAGLIPTIN/METFORMIN XR | 500 BTL | Actual shortage | 2025-11-13 | 2025-11-27 | 271847 |
Showing 1 to 6 of 6
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0